Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 2Leukemia, Myelomonocytic, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia 1Congenital Abnormalities 1

Interventions

Cytarabine 23Busulfan 12Peripheral Blood Stem Cell Transplantation 11Cyclophosphamide 10fludarabine phosphate 9Filgrastim 9Cyclosporine 9Antilymphocyte Serum 9Idarubicin 8Methotrexate 7sargramostim 6Mitoxantrone 6Gemtuzumab 6Etoposide 6Daunorubicin 6Radiotherapy 5tipifarnib 4Whole-Body Irradiation 4alvocidib 3Vorinostat 3Tacrolimus 3Mycophenolic Acid 3Methylprednisolone 3Flow Cytometry 3Cytogenetic Analysis 3Cyclosporins 3Clofarabine 3Azacitidine 3merphos 2Topotecan 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Leukemia, Megakaryoblastic, Acute × choline magnesium trisalicylate × Clear all
NCT02144675 2021-08-24

Choline Magnesium Trisalicylate and Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia

Rutgers, The State University of New Jersey

Phase 2 Completed
27 enrolled 9 charts
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡